The Food and Drugs Administration (FDA) on Friday said no applications  have been filed for amendments of the emergency use authorizations (EUA) of Covid-19 booster shots for children five to 11 years old. ,“There are no applications yet for booster doses for five to 11 years old. If in case there will be, we will try to evaluate it within three weeks,” FDA officer-in-charge Oscar Gutierrez said in an interview in the Laging Handa public briefing. ,Gutierrez assured the public that the regulatory body will hasten the evaluation of vaccines should a vaccine manufacturer decide to file for an amendment on its EUA. ,The statement came after the United States-FDA granted the EUA for a booster dose of Pfizer/BioNTech’s Covid-19 vaccine for children ages five to 11,  at least five months after completion of the primary vaccine series.,So far, the third dose of Covid-19 vaccine is only limited to minors aged 12 to 17 years old. ,Earlier, vaccine czar Carlito Galvez Jr. said the government is eyeing to vaccinate 90 percent of the student population against Covid-19 in preparation for the conduct of smooth face-to-face classes.,“This is what we really wanted, we want to vaccinate at least 90 percent of the students, so we won’t have any problems in the face-to-face (classes),” Galvez said in a statement. ,Since the government started the rollout of Covid-19 vaccines for children aged five to 11 years old, there are now a total of 2.46 million fully vaccinated children, according to the National Vaccination Operations Center. ,This is equivalent to 17.6 percent of the target population of the 14 million children who belong to the age group in the country. ,Meanwhile, there are 9.3 million children aged 12-17 years old who are fully vaccinated against the dreaded respiratory disease. This is equivalent to 81 percent of the target population. ,Last week, the country’s pandemic task force expressed its support for the return of in-person classes in all public and private schools for basic education.